NCT02141620View on ClinicalTrials.gov

n-Acetylcysteine and Cocaine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Cocaine AbuseCocaine Dependence
Interventions
DRUG

Cocaine

The pharmacodynamic effects of cocaine will be determined during maintenance on placebo and n-acetylcysteine.

DRUG

n-Acetylcysteine

DRUG

Placebo

Trial Locations (1)

40507

University of Kentucky Laboratory of Human Behavioral Pharmacology, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Kentucky

OTHER

NCT02141620 - n-Acetylcysteine and Cocaine | Biotech Hunter | Biotech Hunter